Joinn Laboratories(China)Co.,Ltd.
603127
Peringkat dalam Saham
#3819
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Harga Saham
$6.82
Kapitalisasi Pasar
$4.30B
Perubahan (1 hari)
-6.30%
Perubahan (1 tahun)
184.21%
Negara
CN
Perdagangan Joinn Laboratories(China)Co.,Ltd. (603127)
Kategori
Healthcare
Riwayat harga saham Joinn Laboratories(China)Co.,Ltd. (603127)
Harga penutupan tertinggi: $3.68 pada 2026-10-01
Harga penutupan terendah: $6.48 pada 2021-02-01
Harga penutupan terendah: $6.48 pada 2021-02-01
Riwayat harga saham Joinn Laboratories(China)Co.,Ltd. dari 2021 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 11.18% |
| 2025 | 111.15% |
| 2024 | -23.74% |
| 2023 | -55.34% |
| 2022 | -30.77% |
| 2021 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
